NVO Q1 2016 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

Q1 2016 Earnings

Reported March 30, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q1 2016	Q4 2015	Q1 2015	QoQ Change	YoY Change
Revenue	$4.3B	—	—	—	—
Op. Income	$1.9B	—	—	—	—
Gross Margin	84.4%	—	—	—	—
Net Margin	34.7%	—	—	—	—
EPS (Diluted)	$0.29	—	—	—	—
Free Cash Flow	$994M	—	—	—	—

Revenue Flow

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$664M
GROSS PROFIT	$3.6B
R&D Expenses	$518M
Selling & Marketing	$1.1B
General & Administrative	$142M
SG&A Expenses	$1.2B
Other Expenses	-$45M
Operating Expenses	$1.7B
Cost & Expenses	$2.3B
OPERATING INCOME	$1.9B
Interest Income	$4M
Interest Expense	$59M
Other Income/Expenses	-$56M
INCOME BEFORE TAX	$1.9B
Income Tax Expense	$392M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$98M
EBIT	$1.9B
EBITDA	$2.0B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$4.3B
Cost of Revenue	$664M
GROSS PROFIT	$3.6B
R&D Expenses	$518M
Selling & Marketing	$1.1B
General & Administrative	$142M
SG&A Expenses	$1.2B
Other Expenses	-$45M
Operating Expenses	$1.7B
Cost & Expenses	$2.3B
OPERATING INCOME	$1.9B
Interest Income	$4M
Interest Expense	$59M
Other Income/Expenses	-$56M
INCOME BEFORE TAX	$1.9B
Income Tax Expense	$392M
Net Income from Continuing Ops	$1.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.5B
D&A	$98M
EBIT	$1.9B
EBITDA	$2.0B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.5B
Depreciation & Amortization	$98M
Stock-Based Compensation	$0
Deferred Income Tax	$392M
Other Non-Cash Items	$156.9K
Change in Working Capital	-$556M
OPERATING CASH FLOW	$1.2B
Capital Expenditure	-$179M
Acquisitions (Net)	$0
Purchases of Investments	-$77M
Sales/Maturities of Investments	$0
Other Investing Activities	$4M
NET CASH FROM INVESTING	-$252M
Net Debt Issuance	$0
Common Stock Repurchased	-$589M
Common Dividends Paid	-$2.5B
Other Financing Activities	$441M
NET CASH FROM FINANCING	-$2.7B
FREE CASH FLOW	$994M
Net Change in Cash	-$1.8B

Balance Sheet

Item	Amount
Cash & Equivalents	$756M
Short-Term Investments	$633M
Net Receivables	$2.6B
Inventory	$2.0B
Other Current Assets	$1.3B
TOTAL CURRENT ASSETS	$7.3B
PP&E (Net)	$4.1B
Goodwill	$0
Intangible Assets	$338M
Long-Term Investments	$307M
Tax Assets	$943M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$5.6B
TOTAL ASSETS	$12.9B
Account Payables	$587M
Short-Term Debt	$64M
Deferred Revenue	$3.4B
Other Current Liabilities	$2.4B
TOTAL CURRENT LIABILITIES	$6.4B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2M
Other Non-Current Liabilities	$629M
TOTAL NON-CURRENT LIABILITIES	$629M
TOTAL LIABILITIES	$7.1B
Common Stock	$82M
Additional Paid-In Capital	$82M
Retained Earnings	$5.7B
Treasury Stock	-$2M
Accum. Other Comp. Income	$111M
Other Equity	-$82M
TOTAL STOCKHOLDERS' EQUITY	$5.9B
Minority Interest	$0
TOTAL EQUITY	$5.9B
TOTAL LIABILITIES & EQUITY	$12.9B
Total Debt	$64M
Net Debt	-$692M